Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lea Ann Hansen"'
Autor:
Jennifer L Thompson, Lea Ann Hansen
Publikováno v:
Annals of Pharmacotherapy. 37:571-576
OBJECTIVE: To evaluate the literature regarding the dosing of thalidomide in multiple myeloma. DATA SOURCES: A MEDLINE search (1990–February 2003) using the search terms thalidomide and multiple myeloma was performed to identify clinical trials and
Autor:
Lea Ann Hansen
Publikováno v:
American Pharmacy. 33:61-69
Publikováno v:
American Journal of Health-System Pharmacy. 48:1477-1483
The impact of a decision analysis model on pharmacists' preferences for a drug therapy was studied. Three hundred forty members of the American College of Clinical Pharmacy were randomly assigned to receive either a copy of a drug therapy review alon
Publikováno v:
Clinical journal of oncology nursing. 9(5)
Patients continue to suffer from pain despite their analgesic regimen and frequently from symptoms related to these interventions. This article describes the role that intrathecal analgesia may play in improving comfort for individuals experiencing r
Publikováno v:
Journal of pain and symptom management. 28(3)
Increasing numbers of patients with refractory pain are receiving intrathecal drug delivery systems (IDDS). We describe a case to illustrate the clinical manifestations and management implications of inadvertent overdose with drugs used in IDDS, incl
Publikováno v:
The American journal of nursing. 103(5)
Compounded medications offer great opportunities for enabling healthcare professionals to control pain or other symptoms through unique delivery routes and nonstandard formulations or dosages. These formulations can include gels, trouches, suspension
Autor:
Lea Ann Hansen
Publikováno v:
Annals of Pharmacotherapy. 38:1754-1755
Autor:
Toni Bjurstrom, Ann E. Gooding, Rita H. Griffin, Rodney Mitchell, Haig P. Bozigian, Timothy L. Panella, J. Frederick Pritchard, Andrew T. Huang, Poe‐Hirr Hsyu, Lea Ann Hansen
Publikováno v:
Journal of clinical pharmacology. 34(7)
The effect of a typical 5-day chemotherapy treatment with cisplatin (20-40 mg/m2 per day) and 5-fluorouracil (5-FU, 1 gm/m2 per day) on the pharmacokinetics of ondansetron was investigated. Twenty cancer patients received 8 mg of ondansetron in three
Publikováno v:
Journal of pain and symptom management. 6(1)
The benefits of two dosing methods, patient-controlled analgesia (PCA) with morphine sulfate (MS) alone and PCA plus continuous infusion of morphine sulfate (PCA + CI) were clinically evaluated in a randomized, single-blinded study of 30 adult abdomi
Autor:
Lea Ann Hansen
Publikováno v:
Annals of Pharmacotherapy. 33:877-878